Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How would you approach an intrathoracic solitary fibrous tumor in a patient who is not a surgical candidate?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · The Ohio State University - James Cancer Hospital and Solove Research Institute

Unresected SFT can have good outcomes with definitive-intent RT: Haas et al., 29859795. SBRT or hypofractionated regimens seem reasonable if the location allows. If not, conventional fractionation to 60-66 Gy.

What criteria do you use to decide between 1 fraction vs multi-fraction (e.g. 5 fractions) for WHO 1 meningiomas?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · GammaWest Cancer Services

This is an important, frequently encountered, and clinically relevant question. I will address it as posed, but intend to emphasize that, although stereotactic radiosurgery (SRS) is an important therapeutic option for WHO grade I meningioma patients requiring RT, it does not displace external beam R...

Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

Yes. I wouldn't see any reason it would be an issue. We know hypofractionation for intact breast is fine. There are no issues with RNI and hypofractionation. So, there should be no issue in combining.

What is appropriate followup duration after treatment for an acoustic neuroma?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Thomas Jefferson University Hospital

Annual follow up is appropriate for most patients, and q6m MRI may not be necessary. If possible, long term follow up of 10 year or longer is prefered. The local control of acoustic neuroma with radiation treatment (SRS or FSRT) is excellent. Most series reported long term control of 95% or higher....

What are your top takeaways in Neuro Oncology from ASTRO 2024?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · GammaWest Cancer Services

A Prospective, Phase II study of 177Lu-Dotatate in patients with surgery- and radiation-refractory meningioma: Results of the WHO grade II/III cohort, presented by Kenneth Merrell. I have spent a large portion of my career emphasizing optimal management for meningioma patients and this study opens ...

How do you approach deciding between SRS and fractionated radiation for an acoustic neuroma?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Offer fractionated RT if patient has serviceable hearing (can use the phone on that side). Otherwise SRS if less than 3 cm. If larger than 3 cm and not a surgical candidate, fractionated RT.

What is your approach to managing follicular lymphoma with central nervous system involvement?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Hackensack University Medical Center

Not really an expert on this issue. Fairly uncommon to have a follicular lymphoma-associated CNS disease. Our usual is for high-dose methotrexate, Temodar, and rituximab. Potentially followed by autologous stem cell transplant.

Would presence of DIEP flap reconstruction impact your decision to proceed with a BID approach to PMRT for inflammatory breast cancer?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

The short answer is no. I would first carefully review the history that led to an IBC patient having immediate reconstruction since immediate reconstruction is not recommended and it warrants a careful review. Ideally, the patient would have upfront photos of skin involvement, bilateral nodal evalua...

For palliation of gastric bleeding due to malignancy, is a G-tube a contraindication for RT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UPMC Hillman Cancer Center

I would not change my approach because of a G-tube and I base my dose/fractionation largely on performance status. This recent systematic review is helpful and highlights that a low BED regimen is typically adequate for effective palliation (Tey et al., PMID 28445941).

Would you offer salvage radiation for biochemically recurrent prostate cancer with a transplanted pelvic kidney?

3
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Utah School of Medicine

You may want to consider a PSMA PET/CT or Fluciclovine PET/CT if the PSA is >=0.2 at 0.2-0.5 about 30% of scans are positive, at 0.5 and up ~ 50% or more. If you had a target it may guide field design. I would also be curious about life expectancy of this patient, PSA doubling time, and time form or...